Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review.
리뷰
1/5 보강
Risk-reduction guidelines for patients with germline pathogenic variants, such as hereditary breast and ovarian cancer and hereditary non-polyposis colorectal cancer, are effective and significantly r
APA
Beshar I, Agusti N, et al. (2026). Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 36(1), 102825. https://doi.org/10.1016/j.ijgc.2025.102825
MLA
Beshar I, et al.. "Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review.." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, vol. 36, no. 1, 2026, pp. 102825.
PMID
41494213 ↗
Abstract 한글 요약
Risk-reduction guidelines for patients with germline pathogenic variants, such as hereditary breast and ovarian cancer and hereditary non-polyposis colorectal cancer, are effective and significantly reduce mortality when implemented. Despite this, uptake of risk-reduction strategies is notably low, especially among medically under-served populations. Barriers to the completion of cancer surveillance, risk-reducing surgical interventions, and chemoprevention are complex and occur at every level in the health care system. In this narrative review article, systematic, clinical, and patient-level barriers to completion of guidelines are described and outlined. In addition, interventions that have emerged to improve the uptake of these interventions are addressed and evaluated for efficacy. These interventions group in 4 main arenas: technologic platforms, multi-disciplinary clinics, decision aids, and psychological support. We comment on the long-term sustainability of these interventions, particularly, in under-served populations and low- to middle-income countries, and highlight areas of impact. We also outline areas of focus for possible future directions and mechanisms for ensuring interventions are equitable, holistic, and rigorously assessed for efficacy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.